37.90NOK+5.28%Mkt Cap: 54.77M $P/E: —1d ago
Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. It offers in-vitro diagnostic reagents for clinical chemi…
Indicators:|
Key Statistics
Company
Market Cap54.77M $
Enterprise Value47.71M $
Revenue (TTM)16.44M $
Gross Profit9.18M $
Net Income (TTM)1.24M $
Revenue/Share1.066 USD
Last Price37.90 NOK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees63
CountryNO
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)9.67
PEG—
EV/EBITDA26.14
EV/Revenue2.90
P/S3.33
P/B3.16
EPS (TTM)-0.96
EPS (Forward)3.92
52W Range
33.5014% of range65.80
52W High65.80 NOK
52W Low33.50 NOK
Profitability
Gross Margin55.64%
Oper. Margin6.17%
EBITDA Margin11.10%
Profit Margin7.51%
ROE6.47%
ROA5.13%
Growth
Revenue Growth-1.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.98M $
CapEx (TTM)1.01M $
FCF Margin4.10%
FCF Yield1.23%
Net Debt-6.93M $
Net Debt/EBITDA-3.80
Balance Sheet
Debt/Equity0.11
Current Ratio5.70
Quick Ratio4.01
Book Value/Sh12.01 NOK
Cash/Share5.957 NOK
Dividends
Fwd Div Rate0.6000 NOK
Trail. Div Rate0.6000 NOK
Div. Yield1.58%
5Y Avg Yield—
Payout Ratio46.51%
Ex-Div DateMay 6, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)60.00 NOK
Upside (mean)+58.3%
Target Range60.00 NOK – 60.00 NOK
# Analysts1
Ownership
Shares Out.15.46M
Float11.67M
Insiders44.62%
Institutions39.98%
Technical
SMA 5038.53 (-1.6%)
SMA 20047.94 (-20.9%)
Beta0.40
S&P 52W Chg20.05%
Avg Vol (30d)5.79K
Avg Vol (10d)3.46K
Technical Indicators
RSI (14)55.0
MACD-0.5022
MACD Signal-0.8190
MACD Hist.+0.3168
BB Upper38.16 NOK
BB Middle36.05 NOK
BB Lower33.95 NOK
BB Width11.69%
ATR (14)1.976 NOK
Vol Ratio (20d)2.98x